vs
Side-by-side financial comparison of STEM, INC. (STEM) and TrueCar, Inc. (TRUE). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $43.2M, roughly 1.1× TrueCar, Inc.). TrueCar, Inc. runs the higher net margin — 11.6% vs -33.9%, a 45.5% gap on every dollar of revenue. On growth, TrueCar, Inc. posted the faster year-over-year revenue change (-7.2% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 2.3%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
TrueCar, Inc. is an American car retailing website company headquartered in Santa Monica, California. It also maintains a sales office in Austin, Texas.
STEM vs TRUE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.1M | $43.2M |
| Net Profit | $-16.0M | $5.0M |
| Gross Margin | 48.9% | — |
| Operating Margin | -17.7% | -17.0% |
| Net Margin | -33.9% | 11.6% |
| Revenue YoY | -15.6% | -7.2% |
| Net Profit YoY | 68.8% | 185.7% |
| EPS (diluted) | $-4.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.1M | — | ||
| Q3 25 | $38.2M | $43.2M | ||
| Q2 25 | $38.4M | $47.0M | ||
| Q1 25 | $32.5M | $44.8M | ||
| Q4 24 | $55.8M | $46.2M | ||
| Q3 24 | $29.3M | $46.5M | ||
| Q2 24 | $34.0M | $41.8M | ||
| Q1 24 | $25.5M | $41.1M |
| Q4 25 | $-16.0M | — | ||
| Q3 25 | $-23.8M | $5.0M | ||
| Q2 25 | $202.5M | $-7.6M | ||
| Q1 25 | $-25.0M | $-10.1M | ||
| Q4 24 | $-51.1M | $-5.8M | ||
| Q3 24 | $-148.3M | $-5.8M | ||
| Q2 24 | $-582.3M | $-13.5M | ||
| Q1 24 | $-72.3M | $-5.8M |
| Q4 25 | 48.9% | — | ||
| Q3 25 | 35.5% | — | ||
| Q2 25 | 33.4% | — | ||
| Q1 25 | 32.4% | — | ||
| Q4 24 | -4.4% | — | ||
| Q3 24 | 21.2% | — | ||
| Q2 24 | 27.6% | — | ||
| Q1 24 | -95.0% | — |
| Q4 25 | -17.7% | — | ||
| Q3 25 | -33.6% | -17.0% | ||
| Q2 25 | -34.8% | -18.3% | ||
| Q1 25 | -65.0% | -25.0% | ||
| Q4 24 | -84.4% | -15.4% | ||
| Q3 24 | -493.2% | -15.9% | ||
| Q2 24 | -1705.5% | -36.3% | ||
| Q1 24 | -267.0% | -18.2% |
| Q4 25 | -33.9% | — | ||
| Q3 25 | -62.2% | 11.6% | ||
| Q2 25 | 527.8% | -16.2% | ||
| Q1 25 | -76.9% | -22.6% | ||
| Q4 24 | -91.6% | -12.7% | ||
| Q3 24 | -506.3% | -12.5% | ||
| Q2 24 | -1712.6% | -32.3% | ||
| Q1 24 | -283.9% | -14.2% |
| Q4 25 | $-4.40 | — | ||
| Q3 25 | $-2.84 | — | ||
| Q2 25 | $-1.79 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-15.29 | — | ||
| Q3 24 | $-18.24 | — | ||
| Q2 24 | $-71.81 | — | ||
| Q1 24 | $-0.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $48.9M | $103.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-249.4M | $114.2M |
| Total Assets | $308.9M | $148.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.9M | — | ||
| Q3 25 | $43.1M | $103.2M | ||
| Q2 25 | $40.8M | $92.5M | ||
| Q1 25 | $58.6M | $98.0M | ||
| Q4 24 | $56.3M | $111.8M | ||
| Q3 24 | $75.4M | $114.5M | ||
| Q2 24 | $89.6M | $128.0M | ||
| Q1 24 | $112.8M | $133.7M |
| Q4 25 | $-249.4M | — | ||
| Q3 25 | $-235.7M | $114.2M | ||
| Q2 25 | $-214.1M | $106.4M | ||
| Q1 25 | $-417.5M | $111.1M | ||
| Q4 24 | $-398.4M | $118.1M | ||
| Q3 24 | $-344.1M | $128.0M | ||
| Q2 24 | $-203.2M | $143.9M | ||
| Q1 24 | $371.6M | $156.0M |
| Q4 25 | $308.9M | — | ||
| Q3 25 | $362.6M | $148.7M | ||
| Q2 25 | $379.2M | $139.8M | ||
| Q1 25 | $405.1M | $145.0M | ||
| Q4 24 | $437.4M | $159.7M | ||
| Q3 24 | $537.8M | $167.5M | ||
| Q2 24 | $691.5M | $183.0M | ||
| Q1 24 | $1.3B | $193.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $12.7M |
| Free Cash FlowOCF − Capex | — | $11.2M |
| FCF MarginFCF / Revenue | — | 25.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | $11.4M | $12.7M | ||
| Q2 25 | $-21.3M | $-2.8M | ||
| Q1 25 | $8.5M | $-7.9M | ||
| Q4 24 | $-14.7M | $5.9M | ||
| Q3 24 | $-9.4M | $1.8M | ||
| Q2 24 | $-11.9M | $-2.0M | ||
| Q1 24 | $-621.0K | $2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $11.2M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $-10.6M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | $-170.0K | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | — | $-511.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.9% | ||
| Q2 25 | — | -10.2% | ||
| Q1 25 | — | -23.6% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | -8.7% | ||
| Q1 24 | — | -1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 3.9% | ||
| Q1 24 | — | 6.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.55× | ||
| Q2 25 | -0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
